|
|
|
|
NOTICES |
|
Notice No. |
|
20250114-9 |
|
Notice Date |
|
14 Jan 2025 |
|
Category |
|
Corporate Actions |
|
Segment |
|
Debt |
|
Subject |
|
Suspension of Trading in Commercial Paper |
|
|
|
|
|
Content |
|
|
Trading Members of the Exchange are hereby informed that under mentioned Commercial Paper shall mature as on the Maturity Date :-
Sr. No.
|
Scrip Code
|
Company Name
|
Particulars
|
ISIN
|
1
|
728087
|
Mankind Pharma Limited
|
MPL-16-1-25-CP
|
INE634S14021
|
Hence, Trading Members are advised not to deal in aforesaid Commercial Paper of the Company with effect from January 15, 2025 (DR-799/2024-2025).
Trading Members of the Exchange are requested to take note of it.
Marian Dsouza
Senior Manager – Listing Operations (CRD)
January 14, 2025 |
|